Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Who funded the research behind the Oxford-AstraZeneca COVID-19 vaccine?
Cross S, Rho Y, Reddy H, Pepperrell T, Rodgers F, Osborne R, Eni-Olotu A, Banerjee R, Wimmer S, Keestra S. Cross S, et al. Among authors: rho y. BMJ Glob Health. 2021 Dec;6(12):e007321. doi: 10.1136/bmjgh-2021-007321. BMJ Glob Health. 2021. PMID: 34937701 Free PMC article.
Combating Discrimination in Medical Education.
Salazar O, Rho YU. Salazar O, et al. JAMA Intern Med. 2020 Jul 1;180(7):1029-1030. doi: 10.1001/jamainternmed.2020.1593. JAMA Intern Med. 2020. PMID: 32478798 No abstract available.
SB16 versus reference denosumab in postmenopausal women with osteoporosis: 18-month outcomes of a phase III randomized clinical trial.
Chung YS, Langdahl B, Plebanski R, Czerwinski E, Dokoupilova E, Supronik J, Rosa J, Mydlak A, Sapula R, Rowińska-Osuch A, Baek KH, Urboniene A, Mordaka R, Ahn S, Rho YH, Ban J, Eastell R. Chung YS, et al. Among authors: rho yh. Bone. 2025 Mar;192:117371. doi: 10.1016/j.bone.2024.117371. Epub 2024 Dec 12. Bone. 2025. PMID: 39674388 Free article. Clinical Trial.
Biosimilar SB17 versus reference ustekinumab in moderate to severe plaque psoriasis after switching: phase 3 study results up to week 52.
Feldman SR, Narbutt J, Girolomoni G, Brzezicki J, Reznichenko N, Zegadło-Mylik MA, Pulka G, Dmowska-Stecewicz M, Kłujszo E, Rekalov D, Rajzer L, Lee J, Lee M, Rho YH. Feldman SR, et al. Among authors: rho yh. J Dermatolog Treat. 2024 Dec;35(1):2436607. doi: 10.1080/09546634.2024.2436607. Epub 2024 Dec 10. J Dermatolog Treat. 2024. PMID: 39658004 Free article. Clinical Trial.
Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12.
Langdahl B, Chung YS, Plebanski R, Czerwinski E, Dokoupilova E, Supronik J, Rosa J, Mydlak A, Rowińska-Osuch A, Baek KH, Urboniene A, Mordaka R, Ahn S, Rho YH, Ban J, Eastell R. Langdahl B, et al. Among authors: rho yh. J Clin Endocrinol Metab. 2024 Sep 7:dgae611. doi: 10.1210/clinem/dgae611. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39243386 Free article.
382 results